Qurgen
Troy Mills
About Qurgen
Qurgen is a biotechnology company that focuses on the development of efficient protein in vitro and in vivo Cell and tissue reprogramming technology. It features the breakthrough protein targeted transport and efficient in vitro and in vivo protein-induced stem cells and other patented technologies. The company was founded in 2016 and headquartered in Iowa, United States.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $9.7M
- Last round: Series Unknown (Feb 2018)
- Website: qurgen.com
- Phone: +1 248-680-9975
Industries & Categories
Biotechnology, Clinical Trials, Life Science
Canonical: https://fsome.com/organization/qurgen-177770 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.